Latest Breaking News On - Office therapy - Page 3 : vimarsana.com

Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment Company Prepares for Commercialization of Revolutionary In-Office Therapy Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B financing. The round was led by new investor LSP, from its LSP HEF-2 fund, and co-led by Atlantic Bridge, investing from its Growth Fund IV. Fountain Healthcare Partners also participated as a returning investor with strong participation in the round. The financing will support the expansion of the company s clinical and commercial operations as it prepares for U.S. Food and Drug Administration (FDA) clearance and U.S. commercialization of its proprietary NEUROMARK Rhinitis Neurolysis Therapy, an innovative in-office treatment for chronic rhinitis.

United statesBaden wubergNoord hollandGerry maguireKostenloser wertpapierhandelJessica stebingZealand pharmaCompany prepares for commercialization of revolutionaryLoncode instituteGrowth fundOffice therapyDrug administrationDutch venture initiativeCompany preparesRevolutionary in office therapyAtlantic bridge